Go Pro

Mitchell S. Kapoor Analyst Performance

Analyst at HC Wainwright

Mitchell S. Kapoor is a stock analyst at HC Wainwright focused in the medical sector, covering 29 publicly traded companies. Over the past year, Mitchell S. Kapoor has issued 96 stock ratings, including buy, hold, and sell recommendations. While full access to Mitchell S. Kapoor's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Mitchell S. Kapoor's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
96 Last 0 Years
Buy Recommendations
84.38% 81 Buy Ratings
Companies Covered
29 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy84.4%81 ratings
Hold10.4%10 ratings
Sell5.2%5 ratings

Out of 96 total stock ratings issued by Mitchell S. Kapoor at HC Wainwright, the majority (84.4%) have been Buy recommendations, followed by 10.4% Hold and 5.2% Sell.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NASDAQ
96.6% of companies on NASDAQ
28 companies
NYSE
3.4% of companies on NYSE
1 company

Mitchell S. Kapoor, an analyst at HC Wainwright, currently covers 29 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
27 companies
93.1%
Manufacturing
2 companies
6.9%

Mitchell S. Kapoor of HC Wainwright specializes in stock coverage within the Medical sector, with additional focus on Manufacturing companies.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
18 companies
62.1%
MED - DRUGS
9 companies
31.0%
Miscellaneous
2 companies
6.9%

Mitchell S. Kapoor's Ratings History at HC Wainwright

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
7/10/2026Lower Price Target$60.16$125.00Buy
MeiraGTx Holdings PLC stock logo
MGTX
MeiraGTx
7/8/2026Reiterated Rating$14.66$20.00Buy
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
7/8/2026Reiterated Rating$60.77$80.00Buy
Incyte Corporation stock logo
INCY
Incyte
6/24/2026Reiterated Rating$104.40$140.00Buy
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
6/23/2026Reiterated Rating$85.38$120.00Buy
Damora Therapeutics, Inc. Common Stock stock logo
DMRA
Damora Therapeutics, Inc. Common Stock
6/11/2026Initiated Coverage$20.15$45.00Buy
Lyell Immunopharma, Inc. stock logo
LYEL
Lyell Immunopharma
6/9/2026Reiterated Rating$12.31$45.00Buy
Neurogene Inc. stock logo
NGNE
Neurogene
6/9/2026Reiterated Rating$28.60$70.00Buy
Incyte Corporation stock logo
INCY
Incyte
6/9/2026Boost Price Target$103.11$140.00Buy
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
6/3/2026Boost Price Target$36.28$65.00Buy
Lyell Immunopharma, Inc. stock logo
LYEL
Lyell Immunopharma
6/3/2026Reiterated Rating$14.89$45.00Buy
Kyverna Therapeutics, Inc. stock logo
KYTX
Kyverna Therapeutics
6/3/2026Reiterated Rating$7.86$25.00Buy
Evommune, Inc. stock logo
EVMN
Evommune
5/26/2026Reiterated Rating$22.74$50.00Buy
Korro Bio, Inc. stock logo
KRRO
Korro Bio
5/19/2026Lower Price Target$9.97$15.00Buy
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
5/18/2026Reiterated Rating$27.55$50.00Buy
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
5/18/2026Reiterated Rating$61.93$120.00Buy
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
5/18/2026Lower Price Target$50.63$50.00Neutral
Alumis Inc. stock logo
ALMS
Alumis
5/15/2026Downgrade$24.63$25.00Neutral
Kyverna Therapeutics, Inc. stock logo
KYTX
Kyverna Therapeutics
5/15/2026Boost Price Target$10.74$25.00Buy
Tyra Biosciences, Inc. stock logo
TYRA
Tyra Biosciences
5/14/2026Reiterated Rating$36.18$45.00Buy
Avalo Therapeutics, Inc. stock logo
AVTX
Avalo Therapeutics
5/14/2026Lower Price Target$19.85$35.00Buy
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
5/13/2026Lower Price Target$13.99$25.00Buy
Cartesian Therapeutics, Inc. stock logo
RNAC
Cartesian Therapeutics
5/12/2026Lower Price Target$8.53$25.00Buy
CytomX Therapeutics, Inc. stock logo
CTMX
CytomX Therapeutics
5/11/2026Lower Price Target$3.98$11.00Buy
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
5/5/2026Reiterated Rating$55.46$55.00Neutral
Incyte Corporation stock logo
INCY
Incyte
5/4/2026Reiterated Rating$96.91$135.00Buy
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
5/4/2026Lower Price Target$16.11$23.00Buy
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
4/29/2026Boost Price Target$63.86$95.00Buy
Kyverna Therapeutics, Inc. stock logo
KYTX
Kyverna Therapeutics
4/23/2026Reiterated Rating$10.23$20.00Buy
Century Therapeutics, Inc. stock logo
IPSC
Century Therapeutics
4/21/2026Boost Price Target$2.34$5.00Buy
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
4/21/2026Reiterated Rating$25.07$50.00Buy
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
4/16/2026Reiterated Rating$21.07Sell
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
4/15/2026Reiterated Rating$18.69$50.00Buy
Incyte Corporation stock logo
INCY
Incyte
4/15/2026Reiterated Rating$97.69$135.00Buy
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
4/13/2026Boost Price Target$59.58$70.00Buy
Generate Biomedicines Inc stock logo
GENB
Generate Biomedicines
4/13/2026Initiated Coverage$11.41$16.00Buy
Alumis Inc. stock logo
ALMS
Alumis
3/30/2026Lower Price Target$24.80$25.00Buy
Palisade Bio, Inc. stock logo
PALI
Palisade Bio
3/26/2026Initiated Coverage$2.00$7.00Buy
Incyte Corporation stock logo
INCY
Incyte
3/25/2026Reiterated Rating$90.62$135.00Buy
Avalo Therapeutics, Inc. stock logo
AVTX
Avalo Therapeutics
3/25/2026Boost Price Target$13.45$40.00Buy
Do NOT Buy SpaceX – Do This Instead (Ad)

SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now.tc pixel

Read Tilson's free analysis and find out what to do with your money
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
3/25/2026Boost Price Target$73.05$120.00Buy
Evommune, Inc. stock logo
EVMN
Evommune
3/18/2026Lower Price Target$24.99$50.00Buy
CytomX Therapeutics, Inc. stock logo
CTMX
CytomX Therapeutics
3/16/2026Boost Price Target$7.81$17.00Buy
Incyte Corporation stock logo
INCY
Incyte
3/9/2026Reiterated Rating$95.94$135.00Buy
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
3/3/2026Boost Price Target$15.44$30.00Buy
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
3/2/2026Reiterated Rating$16.76Sell
Crescent Biopharma, Inc. stock logo
CBIO
Crescent Biopharma
3/2/2026Lower Price Target$12.09$22.00Buy
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
2/25/2026Lower Price Target$62.62$55.00Neutral
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
2/24/2026Lower Price Target$16.09$30.00Buy
Incyte Corporation stock logo
INCY
Incyte
2/11/2026Reiterated Rating$100.05$135.00Buy
Evommune, Inc. stock logo
EVMN
Evommune
2/10/2026Boost Price Target$25.02$65.00Buy
Incyte Corporation stock logo
INCY
Incyte
2/5/2026Initiated Coverage$102.60$135.00Buy
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
2/2/2026Reiterated Rating$14.48$40.00Buy
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
1/27/2026Reiterated Rating$22.80Sell
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
1/22/2026Lower Price Target$20.76$50.00Buy
Avalo Therapeutics, Inc. stock logo
AVTX
Avalo Therapeutics
1/15/2026Reiterated Rating$16.19$25.00Buy
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
1/14/2026Reiterated Rating$21.46Sell
Neurogene Inc. stock logo
NGNE
Neurogene
1/13/2026Reiterated Rating$17.28$70.00Buy
Instil Bio, Inc. stock logo
TIL
Instil Bio
1/7/2026Reiterated Rating$7.03Neutral
Evommune, Inc. stock logo
EVMN
Evommune
1/6/2026Initiated Coverage$15.26$35.00Buy
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
12/22/2025Boost Price Target$61.15$60.00Neutral
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
12/19/2025Reiterated Rating$65.11$90.00Buy
Lyell Immunopharma, Inc. stock logo
LYEL
Lyell Immunopharma
11/24/2025Reiterated Rating$19.13$20.00Neutral
Cartesian Therapeutics, Inc. stock logo
RNAC
Cartesian Therapeutics
11/19/2025Lower Price Target$7.62$30.00Buy
Neurogene Inc. stock logo
NGNE
Neurogene
11/13/2025Boost Price Target$31.08$70.00Buy
Korro Bio, Inc. stock logo
KRRO
Korro Bio
11/13/2025Reiterated Rating$31.42Neutral
CytomX Therapeutics, Inc. stock logo
CTMX
CytomX Therapeutics
11/11/2025Boost Price Target$4.19$10.00Buy
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
11/10/2025Lower Price Target$9.52$15.00Buy
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
11/10/2025Boost Price Target$73.55$110.00Buy
Kyverna Therapeutics, Inc. stock logo
KYTX
Kyverna Therapeutics
10/27/2025Boost Price Target$7.44$20.00Buy
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
10/27/2025Lower Price Target$52.67$55.00Neutral
Lexeo Therapeutics, Inc. stock logo
LXEO
Lexeo Therapeutics
10/21/2025Lower Price Target$9.22$13.00Buy
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
10/17/2025Lower Price Target$32.36$60.00Buy
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
10/15/2025Reiterated Rating$66.65$90.00Buy
Neurogene Inc. stock logo
NGNE
Neurogene
10/9/2025Reiterated Rating$28.20$45.00Buy
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
10/8/2025Reiterated Rating$68.94$95.00Buy
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
10/2/2025Boost Price Target$74.94$90.00Buy
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
9/23/2025Reiterated Rating$62.10$80.00Buy
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
9/23/2025Reiterated Rating$61.36$95.00Buy
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
9/22/2025Boost Price Target$77.81$85.00Buy
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
9/19/2025Boost Price Target$16.11$30.00Buy
Avalo Therapeutics, Inc. stock logo
AVTX
Avalo Therapeutics
9/17/2025Boost Price Target$11.13$25.00Buy
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
9/16/2025Reiterated Rating$18.94$50.00Buy
Instil Bio, Inc. stock logo
TIL
Instil Bio
9/11/2025Reiterated Rating$24.16$125.00Buy
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
9/8/2025Reiterated Rating$25.98$50.00Buy
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
9/8/2025Initiated Coverage$57.77$60.00Neutral
Editas Medicine, Inc. stock logo
EDIT
Editas Medicine
9/5/2025Reiterated Rating$2.52$5.00Buy
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
9/2/2025Reiterated Rating$23.70$50.00Buy
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
9/2/2025Boost Price Target$42.63$95.00Buy
Kyverna Therapeutics, Inc. stock logo
KYTX
Kyverna Therapeutics
8/29/2025Boost Price Target$3.70$10.00Buy
A letter from Shannon Stansberry (Ad)

Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.tc pixel

Watch the full story and see the verified track record for yourself
Crescent Biopharma, Inc. stock logo
CBIO
Crescent Biopharma
8/27/2025Reiterated Rating$14.47$25.00Buy
Instil Bio, Inc. stock logo
TIL
Instil Bio
8/27/2025Reiterated Rating$28.41$125.00Buy
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
8/25/2025Reiterated Rating$20.22Sell
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
8/22/2025Boost Price Target$43.24$70.00Buy
Tyra Biosciences, Inc. stock logo
TYRA
Tyra Biosciences
8/22/2025Reiterated Rating$11.70$30.00Buy
Editas Medicine, Inc. stock logo
EDIT
Editas Medicine
8/15/2025Boost Price Target$2.96$5.00Buy